Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroleptic-induced hyperprolactinemia.

R A Dickson1, W M Glazer

  • 1Department of Psychiatry, University of Calgary, Peter Lougheed Centre of the Calgary General Hospital, Alb., Canada.

Schizophrenia Research
|April 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standards of care in cauda equina syndrome.

British journal of neurosurgery·2016
Same author

Chemical constituents from Gouania longipetala and Glyphaea brevis.

Natural product research·2014
Same author

Tumor prostheses for bone and joint reconstruction.

Orthopedics·2014
Same author

Proceedings of the tenth open scientific meeting of the hip society 1982.

Orthopedics·2014
Same author

Recent advances in orthopaedics.

Orthopedics·2014
Same author

Antibacterial, anti-inflammatory, and antioxidant effects of the leaves and stem bark of Glyphaea brevis (Spreng) Monachino (Tiliaceae): A comparative study.

Pharmacognosy research·2011
Same journal

Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals.

Schizophrenia research·2026
Same journal

FL-SDGIN: A federated graph learning approach for schizophrenia diagnosis integrating static and dynamic brain functional networks.

Schizophrenia research·2026
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
See all related articles

Neuroleptic-induced hyperprolactinemia (NIHP) is a side effect of traditional antipsychotics. Newer, selective drugs may prevent NIHP, making understanding its consequences and management crucial.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Pharmacology

Background:

  • Neuroleptic-induced hyperprolactinemia (NIHP) is a common adverse effect of traditional antipsychotic medications.
  • The elevation of serum prolactin levels has been an accepted consequence of antipsychotic therapy, often overlooked due to efficacy concerns.

Purpose of the Study:

  • To highlight the clinical significance of NIHP, a condition often accepted as a cost of traditional antipsychotic treatment.
  • To emphasize the importance of understanding NIHP consequences and management with the advent of prolactin-sparing antipsychotics.

Main Methods:

  • Review of existing literature on neuroleptic-induced hyperprolactinemia.
  • Analysis of the implications of hyperprolactinemia in the context of traditional and novel antipsychotic therapies.

Related Experiment Videos

Main Results:

  • Traditional neuroleptics consistently elevate prolactin levels, leading to NIHP.
  • The clinical consequences of NIHP have been historically under-addressed.
  • Newer antipsychotics with selective dopamine blockade may minimize or prevent NIHP.

Conclusions:

  • The development of prolactin-sparing antipsychotics presents an opportunity to avoid NIHP.
  • Clinicians must now prioritize understanding the short- and long-term effects of hyperprolactinemia.
  • Effective management strategies for NIHP are essential given the potential for prevention.